Design and operation of a current good manufacturing practices cell-engineering laboratory

被引:19
作者
Burger, SR [1 ]
机构
[1] Univ Minnesota, Fairview Univ Med Ctr, Cell Therapy Clin Lab, Minneapolis, MN 55455 USA
关键词
D O I
10.1080/146532400539116
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Medical centers and biotechnology companies active in cellular and gene therapy increasingly are working to design and build clinical laboratories capable of performing cellular engineering and vector production using current good manufacturing practices (cGMPs). Because cell engineering is a rapidly changing field, and definitions for cell engineering cGMPs are still being established, a cGMP cell-engineering laboratory most often should be designed with a broad range of potential applications in mind. While the laboratory facility is the most tangible aspect of cGMP, it represents only part of a larger process, which it must be designed and built to support.
引用
收藏
页码:111 / 122
页数:12
相关论文
共 22 条
[1]  
Akers J, 1997, PDA J PHARM SCI TECH, V51, P72
[2]  
BADER FG, 1992, BIOPHARM, V6, P32
[3]  
BURGER SR, 2000, IN PRESS CELLULAR TH
[4]  
*CTR DEV RAD HLTH, 1997, MED DEV QUAL SYST MA
[5]  
*FOOD DRUG ADM CTR, 1996, FDA FOR 1996 GEN THE
[6]   MULTIUSE BIOPHARMACEUTICAL MANUFACTURING [J].
HAMERS, MN .
BIO-TECHNOLOGY, 1993, 11 (05) :561-&
[7]  
Harvath L, 1999, Cytotherapy, V1, P358
[8]  
Hertroys R, 1997, PDA J PHARM SCI TECH, V51, P52
[9]  
HILL D, 1989, BIOPHARM, V10, P20
[10]   An academic centre for gene therapy research with clinical grade manufacturing capability [J].
Islam, KB ;
Blomberg, P ;
Wikström, K ;
Smith, CIE .
ANNALS OF MEDICINE, 1997, 29 (06) :579-583